Think electronic reminders in the EMR change practice? They DO NOT! See the results of NUDGE-CKD: jacc.org/doi/10.1016/j.jacc.… #JACC #CKD #GDMT @niklasdj1 @ankeetbhatt @mvaduganathan @matslassen @TorBiering @KristofferSkaar

🫀Influenza may be a major contributor to adverse outcomes in atrial fibrillation. A nationwide Danish study by @Espersen_C and colleagues from @CTCPR_, published in Heart Rhythm, followed >140,000 patients with AF across 8 influenza seasons. Key findings • Influenza activity was associated with: — 298 excess deaths/year — 86 excess cardiovascular deaths/year — 387 excess pneumonia/influenza hospitalizations/year • The burden was substantially higher than in individuals without AF 💡Influenza prevention may be an overlooked opportunity to improve outcomes in patients with AF. Study link: sciencedirect.com/science/ar… @TorBiering @CopCard @RigsHeart @HGHHjerte @Stenodiabetes

🏆A while ago, our founder, Professor @TorBiering, received @cardio_dk and Hjerteforeningen Research Award 2026. The award recognizes outstanding contributions to cardiovascular research and is a well-deserved recognition of Tor's many years of dedication to advancing cardiovascular science, building innovative research infrastructure, and mentoring the next generation of researchers. We are incredibly proud to see this achievement recognized. Congratulations from your team at @CTCPR_ ! 👏 Read more about Tor and the award below 👇 via.ritzau.dk/pressemeddelel… @CopCard @RigsHeart @HGHHjerte @Stenodiabetes

💉Does diabetes change the benefit of high-dose influenza vaccination? A new prespecified DANFLU-2 analysis by @AnneBjergn and colleagues from @CTCPR_, published in @JAMAInternalMed, included 332,438 adults aged ≥65 years. Key findings • High-dose influenza vaccination was associated with lower risk of cardiorespiratory, cardiovascular, and influenza-related hospitalizations compared with standard-dose vaccination • Benefits were consistent in adults with and without diabetes • The largest cardiorespiratory benefit was observed in those with diabetes duration >5 years (rVE 20.4%) 💡High-dose influenza vaccines may help reduce severe respiratory and cardiovascular outcomes in older adults, regardless of diabetes status. Full study link: jamanetwork.com/journals/jam… @TorBiering @CopCard @RigsHeart @HGHHjerte @Stenodiabetes @RebeccaCHarris @matslassen @KristofferSkaar @niklasdj1 @AM_reimer @dons_maria @KBernholm @fdavidovski_MD @LisaSteenDuus @camillaiottosen @Espersen_C @drJBorchsenius @katjabartholdy @AdamLanghoff @MortenSengelov @MananPareekMD @KiraJanstrup

The link between respiratory infections & chronic disease is no longer in doubt - but how do we act on it? Today's #IDC meeting convened #NCDs, risk groups, leading scientists & experts, to discuss this very question. Here's the key message we heard... (🧵 1/5) #ESWI #NCDIDC

🔟 Days to Go Until #ESWISummit 2026!  Join leading voices in #Science and #Policy as we come together to build a "United Front for Respiratory Health” #RSV #Influenza #COVID19 #hMPV ℹ️eswi.org/activities/summits/… #ESWI #EUHealth #SciencePolicyInterface #HealthPolicy #Prevention

Star PhD-student @katjabartholdy presenting LBCT results from the FLUNITY-HD CKD analysis: High-dose vs. standard-dose flu vaccine: ⬇️hospitalization outcomes, largely irrespective of pre-existing CKD @CTCPR_ is proud of you! @TorBiering @fedemartinon @niklasdj1 @HGHHjerte

🫀New @CTCPR_ study in The International Journal of Cardiovascular Imaging Mathilde Zeuthen Pedersen and colleagues show that cardiac diastolic dysfunction is strongly linked to kidney failure risk in CKD. Study design 731 CKD patients followed for 3.8 years with comprehensive echocardiography. Key findings • Severe LV diastolic dysfunction → ~3x higher risk of ESKD • E/e’ >14 → >3x higher risk • Consistent signal across diastolic markers 💡Cardiac function may help identify CKD patients at highest risk of progression. 📄See full study: link.springer.com/article/10… @TorBiering @CopCard @RigsHeart @HGHHjerte @Stenodiabetes @niklasdj1 @matslassen @KristofferSkaar @fwemmer1

🫀Who benefits from subclinical AF screening? A LOOP trial substudy led by @fwemmer1 and colleagues from @CTCPR_, published in the Journal of the @American_Heart, tested whether echocardiographic markers modify the effect of ILR-based SCAF screening on stroke. Study design 1,422 participants were randomized to ILR screening vs usual care (5.5-year follow-up), with echocardiography in a subset (24%). Key insights • No overall stroke reduction with ILR screening (3.9% vs 3.8%) • Conventional echo measures showed no effect modification • Only left atrial contraction strain identified benefit (HR 0.38 in low strain) 💡Atrial function—not standard echo—may help identify patients who benefit from screening. Full study link: ahajournals.org/doi/10.1161/… @TorBiering @CopCard @RigsHeart @HGHHjerte @Stenodiabetes @PeterGodsk

Proud to be part of this innovative team at @CTCPR_ ! 🏥 A big congratulations to our mentor and leader @TorBiering with the award from @cardio_dk 👏🏽🌟

Cannot think of a more deserving person for this award. Congratulations @TorBiering. You deserve every success, not only for your innovative and impactful research, but also for the way you mentor and collaborate with so many. Truly world class.

🫀Can cardiac myosin inhibition improve outcomes in non-obstructive HCM? A new publication by Kaveh Hosseini and colleagues from @CTCPR_, published in Heart Failure Review, highlights findings from the phase 3 ODYSSEY-HCM trial evaluating mavacamten in symptomatic nHCM. Key findings: • Clear biomarker and imaging effects • No significant improvement in functional capacity or quality of life • Reversible reductions in EF required dose interruption in some patients 💡Target engagement alone may not be enough to achieve meaningful clinical benefit in nHCM. Study link: link.springer.com/article/10… @TorBiering @CopCard @RigsHeart @HGHHjerte @Stenodiabetes

Congrats @TorBiering. So well deserved. Brilliant scientist, researcher, colleague and friend. Thanks for inspiring us! @CTCPR_

Extremely proud of friend, colleague, and boss, @TorBiering, for receiving the 2026 Danish Society of Cardiology & Danish Heart Foundation @cardio_dk Research Prize! This award is in recognition of his massively innovative, outstanding research efforts - Tor, you’re the man!

🫀 What is the long-term cardiovascular impact of RSV infection? New nationwide Danish data study from Anders Hviid and colleagues from @CTCPR_, published in @JAMANetworkOpen, followed adults ≥45 years with laboratory-confirmed RSV for 1 year using Danish health registries. Key findings: - RSV was associated with a significant excess risk of cardiovascular events - Highest risks were seen in hospitalized patients, older adults, and those with CVD or diabetes - Cardiovascular risk after RSV was comparable to influenza 💡RSV may be an important contributor to long-term cardiovascular morbidity — highlighting the importance of prevention and vaccination. Full study link: jamanetwork.com/journals/jam… @TorBiering @CopCard @RigsHeart @HGHHjerte @Stenodiabetes

🫀How much of the cardiac risk in psoriasis patients with MASLD is driven by the liver disease itself — and how much by underlying cardiometabolic risk factors? New study by @dons_maria and colleagues from @CTCPR_, published in @JInternMed, examined cardiac structure/function and MASLD in 255 adults with psoriasis. Key findings 👇 ✔️MASLD was linked to worse cardiac function and adverse cardiometabolic profiles ✔️After adjustment, BMI and diabetes were independently associated with myocardial dysfunction 💡Highlights the importance of cardiometabolic risk factor control in psoriasis patients with MASLD. Full study: onlinelibrary.wiley.com/doi/… @TorBiering @CopCard @RigsHeart @HGHHjerte @Stenodiabetes @fdavidovski_MD @KristofferSkaar @AM_reimer @MortenSengelov

🚨 We are hiring 🚨 Please come join our amazing team 👩‍🎓🧑🏽‍🎓

🚨 We are hiring 🚨 Please come join our amazing team 👩‍🎓🧑🏽‍🎓

🚨 We are hiring 🚨 Please come join our amazing team 👩‍🎓🧑🏽‍🎓

🫀Can advanced strain imaging improve risk stratification after CABG? New study by @fdavidovski_MD and colleagues from @CTCPR_, published in the International Journal of Cardiovascular Imaging, examined layer-specific GLS in 641 CABG patients using speckle-tracking echocardiography. Key findings 👇 ✔️Reduced GLS across all myocardial layers was linked to higher mortality ✔️Epicardial GLS remained independently prognostic even after EuroSCORE II adjustment ✔️Layer-specific GLS was associated with HF/CV death outcomes 💡Advanced echocardiographic strain imaging may add important prognostic value after cardiac surgery. Study link: link.springer.com/article/10… @TorBiering @CopCard @RigsHeart @HGHHjerte @Stenodiabetes @matslassen @KristofferSkaar @Espersen_C @MortenSengelov @fwemmer1